Menopausal symptoms

3 trials MedDRA PT
3 Registered trials
0 Recruiting
1 Unique sponsors
1 Unique IMPs
3 Commercial trials
Drug classes (ATC)
ATC code not specified 3
Mechanism of action (INN-stem analysis)
Unknown / small molecule 1 substance
Phase II: 1 Phase I (Other): 2

Filter these 3 trials by country, sponsor, date range and more.

Open in Search → Gap analysis →
Show: 3 trials

Phase II

1 trial
  • Bayer Consumer Care AG Commercial
    ELINZANETANT
    2023-504955-28-01 7 countries 2024 n=84
    Ended

Phase I (Other)

2 trials
  • Bayer Consumer Care AG Commercial
    IMP not specified
    2023-503864-17-00 1 country 2023 n=36
    Ended
  • Bayer Consumer Care AG Commercial
    ELINZANETANT
    2023-503968-16-00 1 country 2023 n=16
    Ended
Sponsor activity
SponsorTypeTrialsPhasesRecruiting
Bayer Consumer Care AG Commercial 3 Phase I (Other), Phase II 0
New trials by year
2023
2
2024
1
← All indication landscapes